Generic Ozempic and Wegovy Could Cost as Little as $3 a Month, Study Finds Generic versions of Novo Nordisk’s blockbuster drugs Ozempic and Wegovy could be available for under $3 …
Tag:
Health care industry
-
-
FDA Vaccine Chief Dr. Vinay Prasad to Depart in April Dr. Vinay Prasad, the director of the Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research, will abandon …
-
The Rise of Wellness ‘Third Spaces’ and the Battle Against Loneliness A growing number of individuals are seeking out “third spaces”—locations beyond home and work—focused on wellness and social connection. …
-
Missouri’s Medicaid and SNAP System Overhaul Delayed Until 2028 Plans to modernize Missouri’s eligibility systems for the Supplemental Nutrition Assistance Program (SNAP) and Medicaid have been delayed until at least …
-
K-Shaped Economy Evident in Gym Industry: Life Time Thrives While Planet Fitness Faces Headwinds The fitness industry is offering a clear signal about the broader U.S. Economy: consumer spending remains …
-
Eli Lilly Launches Zepbound KwikPen for More Convenient Weight Management Eli Lilly and Company announced on Monday the availability of a new delivery option for its blockbuster obesity drug, Zepbound …
-
Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies of the drugmaker’s new Wegovy obesity pill and injections in …
-
New U.S. Dietary Guidelines Emphasize ‘Real Food‘ and Prioritize Protein Table of Contents New U.S. Dietary Guidelines Emphasize ‘Real Food’ and Prioritize Protein A Shift Away From Processed Foods Prioritizing …
-
the U.S. Food and Drug management on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts say could open up …
-
micron’s Boise Expansion to Create Thousands of Jobs Table of Contents micron’s Boise Expansion to Create Thousands of Jobs Project Details and Investment Job Creation Breakdown Economic Impact on Boise …